Murli Krishna Pharma Private Ltd. is a 20-year-old Indian organization that provides a range of innovative solutions to optimize the delivery of pharmaceutical preparations.
We manufacture Pre-Finished Formulation Intermediates and Finished Dosage forms in our plant that is approved by the European Union, WHO, GCC and Jordanian FDA. Our PFI product range is in the form of Pellets & Micro Pellets.
Alphabetical list of our PFI products
Filters Sort results
Reset Apply
Product Name | Percentage | Mesh Size | Release Type | Target Formulations |
|---|---|---|---|---|
15% , 40% | - | Immediate Release | Capsules | Injectables | |
20% , 40% , 7.5% | - | Tastemasked | Capsules | Suspension | Tablets | |
1% , 10mg | - | - | Eye drops | Suspension | |
0.8 % | - | Extended Release | Capsules | Suspension | Tablets | |
0.8 % | - | - | Dry Powder Inhaler | |
- | - | - | Suspension | |
- | - | - | Inhalation | Oral | |
.25% , .88% , 0.5% | - | - | - | |
27.5%, 30%, 33%, 42% & 43.75% | 30#100 , 30#80 | Tastemasked | Capsules | Suspension | Tablets | |
35% , 40% | - | - | - | |
8.5%,13.33%,17%, 20% | - | Delayed Release | Capsules | |
17% , 20% , 22.5% , 23% | - | Dual Delayed Release | Capsules | |
30% , 31.25% | - | Delayed Release | Capsules | |
42.5% | 14#24 | Extended Release | Capsules | |
20%, 30% | - | Immediate Release | Capsules | Tablets | |
17%, 20% | - | Delayed Release | Capsules | |
50% | - | - | Tablets | |
- | - | - | Capsules | Injectables | |
22.5% , 8.5% | 14#18 , 16# 20 , 18#24 , 24#30 , 30#50 | Delayed Release | Capsules | Premix | Tablets | |
2.68% , 5% | - | - | Capsules | Suspension | Tablets |
